메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

Elevating Healthcare Innovation: ICP DAS-BMP Brings Advanced TPU Portfolio at Medtec China 2025

HSINCHU, Sept. 9, 2025 -- ICP DAS-BMP (Biomedical Polymers), a Taiwan-based manufacturer and supplier of medical-grade TPU (thermoplastic polyurethane), is pleased to announce its participation in Medtec China 2025, to be held from September 24 to 26 at the Shanghai World Expo Exhibition & Convention Center. The spotlight of this year's exhibit will be the low-migration ARP-B20 TPU, developed to meet ISO 10993 biocompatibility standards and suitable for 90-day implant applications. Low-migration TPU significantly reduces additive migration during the heat-setting pr
- 김갑성 기자
- 2025-09-09 09:45
의료 혁신의 도약: ICP DAS-BMP, 메디텍 차이나 2025에서 첨단 TPU 포트폴리오 공개

신주 2025년 9월 9일 -- 대만에 본사를 둔 의료용 TPU(열가소성 폴리우레탄)의 제조 및 공급업체인 ICP DAS-BMP(Biomedical Polymers)가 9월 24일부터 26일까지 상하이 세계엑스포전시컨벤션센터(Shanghai World Expo Exhibition & Convention Center )에서 개최되는 메디텍 차이나 2025(Medtec China 2025)에 참가한다고 발표했다. 올해 전시회의 핵심 제품은 내이행성 ARP-B20 TPU로, ISO 10993 생체 적합성 표준을 충족하며 90일간의 체내 이식 분야에 적합하도록 개발됐다. 내이행성 TPU는 열 고정 공정 중 첨가제 이동을 크게 줄여 카테터가 사용 기간 내내 깨끗하고 매끄러운 표면을 유지하도록 돕는다. 15가지 색상 옵션을 제공해 설계 유연성을 높였으며, 특정 임상 요구에 맞는 맞춤형 솔루션 구현이 가능하다. ICP DAS-BMP는 또한 다양한 의료 분야에 활용할 수 있는 다양한 TPU 소재를 선보인다. 기본 Arothane™, Alithane™, Durathane™ TPU(ARP/ALP/ALC 시리즈)는
- 김갑성 기자
- 2025-09-09 09:45
Amorepacific Group Marks 80th Anniversary: Unveils New Vision Slogan "Create New Beauty"

- Aims to achieve 70% in overseas sales and rank among the global top three in premium skincare- Declares mid- to long-term strategy to become a global leader in beauty & wellness SEOUL, South Korea, Sept. 9, 2025 -- The Amorepacific group announced a new leap forward to mark its 80th anniversary. At its anniversary ceremony held on September 4, the company unveiled the goal of KRW 15 trillion in group sales by 2035, alongside its mid- to long-term vision and strategies to become a global leader in beauty and wellness. Experience the full interactive Multichannel N
- 김갑성 기자
- 2025-09-09 09:00
서텍스, SIR-Spheres® Y-90 수지 미세구체, CE 마크 확대 승인 획득

적응증 확대로 유럽 및 CE 마크 적용 지역에서 간암 치료 접근성 향상 워번, 매사추세츠, 2025년 9월 9일 -- 최소 침습 중재적 종양학 솔루션 분야의 선도 기업인 서텍스 메디컬(Sirtex Medical, 이하 '서텍스')이 9월 8일 간암 환자 치료를 위한 SIR-Spheres® Y-90 수지 미세구체에 대해 CE 마크 확대 승인을 받았다고 발표했다. 이번 승인 확대로 원발성 간암뿐만 아니라 이차성 간 전이 환자도 치료 대상에 포함되어, 이미 확립된 표적 치료를 받을 수 있는 환자 범위가 넓어졌다. 매트 슈미트(Matt Schmidt) 서텍스 메디컬 최고경영자(CEO)는 "이번 성과는 단순한 규제 승인을 넘어, 가장 힘든 암 진단에 직면한 환자들에게 희망과 선택권을 되돌려주는 것"이라며, "SIR-Spheres® 접근성을 확대함으로써 더 많은 환자가 가장 필요할 때 잘 견디는 표적 치료 혜택을 받을 수 있도록 보장한다"라고 말했다. 선택적 내부 방사선 치료(SIRT)로 알려진 방사선색전술은 간 동맥을 통해 이트륨-90을 종양에 직접 전달해, 고용량
- 김갑성 기자
- 2025-09-09 05:31
Sirtex Receives Expanded CE Mark Approval for SIR-Spheres® Y-90 Resin Microspheres

Broadened indication increases access to liver cancer treatment across Europe and CE-marked territories. WOBURN, Mass., Sept. 8, 2025 -- Sirtex Medical ("Sirtex"), a leading manufacturer of minimally invasive interventional oncology solutions, today announced that it has received an expanded CE Mark approval for SIR-Spheres® Y-90 resin microspheres for the treatment of patients with liver cancer. With this expansion, eligibility now covers both primary and secondary liver metastases, increasing patient access to a well-established, targeted therapy. "T
- 김갑성 기자
- 2025-09-08 21:00
Nobel Laureate Headlines Global Discussion in Cell & Gene Therapy in London

PISCATAWAY, N.J., Sept. 8, 2025 -- Cell and gene therapies (CGT) are advancing rapidly and are reshaping the future of medicine. From CRISPR-based genome editing to new applications of in vivo and ex vivo cell therapies, scientific breakthroughs are increasingly moving from the laboratory into clinical practice. At the same time, global investment and innovation in the field are accelerating, positioning CGT as one of the fastest-growing areas in life sciences. One of the greatest challenges for the industry lies in translating these advances into lasting patient benefits and sustainab
- 김갑성 기자
- 2025-09-08 20:49
SpaceGut's Precision AI System for Gut Testing Achieves Up to 87% Improvement in Irritable Bowel Syndrome Management

KUALA LUMPUR, Malaysia, Sept. 8, 2025 -- SpaceGut, Malaysia's first AI-powered at-home Gut Microbiome Test Kit, has paved the way for users to take control of their digestive wellness and conditions such as Irritable Bowel Syndrome (IBS) from home. In the 10 months since it was launched, its breakthrough AI-powered gut health testing has been used by more than 500 individuals to extract tailored insights and solutions for improving their gut health and alleviating digestive conditions like IBS. In Malaysia, approximately 14% of the population is affected by IBS, with many facin
- 김갑성 기자
- 2025-09-08 20:37
Medit Expands Orthodontic Suite with Launch of Medit Aligners: Premium Comfort, Precision, and Speed for Modern Orthodontics

NEWPORT BEACH, Calif., Sept. 8, 2025 -- Medit, a global leader in digital dentistry solutions, today announced the launch of Medit Aligners, a premium digital clear aligner solution designed to deliver faster turnaround times and more predictable outcomes for orthodontic patients. Medit Aligners integrate seamlessly with the Medit Orthodontic Suite (MOS), giving orthodontists the ability to simulate, design, and refine treatment plans before sending them directly into production. The result: a flexible, efficient workflow that combines clinical control with world-
- 김갑성 기자
- 2025-09-08 20:30
WuXi AppTec Awarded Gold Medal by EcoVadis Sustainability Rating for Second Consecutive Year

SHANGHAI, Sept. 8, 2025 -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, today announced it has received the Gold Medal by EcoVadis sustainability rating for the second consecutive year. This achievement reflects WuXi AppTec's commitment to sustainability and its ongoing efforts to integrate environmental and social responsibilities into the Company's business strategies and operations. EcoVadis is a leading sustainability rating agency for global supply chains.
- 김갑성 기자
- 2025-09-08 20:00
BrainCo Helps Amputee Showcase Technology at WAIC 2025

BOSTON, Sept. 8, 2025 -- At the 2025 World Artificial Intelligence Conference (WAIC) in August 2025, Gu demonstrated the BrainCo Intelligent Bionic Hand. He played the piano with precision and even explained to attendees how brain-computer interface (BCI) technology enables amputees to control prosthetic devices with their own neural signals. His presentation drew enthusiastic applause, offering the audience a vivid glimpse of how advanced technology is reshaping human potential. BrainCo, a global leader in non-invasive brain-computer interface (BCI) technology, continues to transform
- 김갑성 기자
- 2025-09-08 19:29

이전

61 62 63 64 65 66 67 68 69 70

많이 본 기사

최근기사

2025-11-05_WED

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 11월 05일 09시 20분